Results 41 to 50 of about 547,171 (369)
Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use
AACE Clinical Case Reports, 2022 Background/Objective: Pemigatinib, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, is a novel therapeutic approach for treating cholangiocarcinoma when an FGFR fusion or gene rearrangement is identified.
Akshan Puar, MBBS +6 more
doaj
A rare cause of atraumatic fractures: case series of four patients with tumor-induced osteomalacia
Clinical Diabetes and Endocrinology, 2020 Background Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that presents with hypophosphatemia, bone pain, muscle weakness and fractures.
Debbie W. Chen +4 more
doaj +1 more source
Frontiers in Physiology, 2020 Dietary phosphorus oversupply wastes non-renewable natural resources and raises environmental concerns in animal agriculture. We hypothesized that laying hens do not need large safety margins for dietary phosphorus because of the existence of fibroblast ...
Zhouzheng Ren +8 more
doaj +1 more source
Fibroblast-growth factor 23 promotes terminal differentiation of ATDC5 cells. [PDF]
PLoS ONE, 2017 Fibroblast Growth Factor 23 (FGF23) is well documented as a crucial player in the systemic regulation of phosphate homeostasis. Moreover, loss-of-function experiments have revealed that FGF23 also has a phosphate-independent and local impact on ...
Mathilde Guibert +3 more
doaj +1 more source
The potential impact of the hypovitaminosis D on metabolic complications in obese adolescents - Preliminary results [PDF]
, 2017 Introduction and Objective Vitamin D deficiency is common in obesity; however, its contribution in the development of metabolic complications remains uncertain.
Januś, Dominika +4 more
core +3 more sources
Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]
Jornal Brasileiro de Pneumologia, 2023 Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito +9 more
doaj +1 more source
Action potential propagation and block in a model of atrial tissue with myocyte-fibroblast coupling [PDF]
Mathematical Medicine and Biology: A Journal of the IMA 38(1),
106-131 (2021), 2020 The electrical coupling between myocytes and fibroblasts and the spacial distribution of fibroblasts within myocardial tissues are significant factors in triggering and sustaining cardiac arrhythmias but their roles are poorly understood. This article describes both direct numerical simulations and an asymptotic theory of propagation and block of ...
arxiv +1 more source
Journal of Bone and Mineral Research, 2020 Autosomal dominant hypophosphatemic rickets (ADHR) is caused by mutations impairing cleavage of fibroblast growth factor 23 (FGF23). FGF23 gene expression increases during iron deficiency.
E. Imel +5 more
semanticscholar +1 more source
Comparison of fibroblast-growth factor-23 level between males and female’s broiler using HPLC technique [PDF]
Iraqi Journal of Veterinary Sciences, 2023 Animal public health is crucial concern when considering the role of fibroblast growth factor-23 (FGF-23) in regulating phosphate metabolism. FGF-23 has been associated with to various diseases in animal, such as chronic kidney and cardiovascular disease,
Soulaf J. Kakel, Ayman M. Albanna
doaj +1 more source
European Journal of Clinical Nutrition, 2020 The phosphaturic hormone fibroblast growth factor 23 (FGF23) is a risk marker of cardiovascular and all-cause mortality. We therefore aimed to synthesize the evidence for the effect of vitamin D administration on circulating FGF23 concentrations.
A. Zittermann, H. Berthold, S. Pilz
semanticscholar +1 more source